BPC-157 5mg & TB-500 5mg — Research Bundle
Two of the most studied recovery peptides. In preclinical research, this stack is investigated for tissue repair, recovery and blood-vessel formation.
Original price was: £49.99.£39.99Current price is: £39.99.
-21%BPC-157 & TB-500 is a two-vial recovery research stack — informally known as the “Wolverine stack” — pairing the two most-studied tissue-repair peptides. It is supplied as two separate 5mg vials, not pre-mixed.
The two are paired because they work on different scales: BPC-157 acts locally at the site of injury, while TB-500 works systemically across the whole body. Each has been studied individually in animal research for:
Researchers pair them because these mechanisms are complementary rather than overlapping. It is worth being clear that this rationale comes from each compound’s individual research — the combination itself has not been directly tested in a published study.
See the individual BPC-157 and TB-500 pages, or our guide on BPC-157 and tendon repair. Reconstitute each vial separately with our bacteriostatic water and syringes.
For research use only. These products are intended strictly for laboratory research purposes and are not for human or animal consumption, medical use, or diagnostic use. Not a drug, food, or cosmetic.
It pairs two tissue-repair research peptides — BPC-157 and TB-500 (a Thymosin Beta-4 fragment) — supplied as two separate 5mg vials. It is informally known as the “Wolverine stack” for its focus on recovery research. The two are combined because each works at a different scale of tissue repair.
Each compound has been studied individually in animal research for a different part of the repair process:
The stack is researched on the basis that these cover both the local and the whole-body side of tissue repair.
No. As of 2026 there is no published peer-reviewed study testing BPC-157 and TB-500 together in any model — cell, animal or human. The individual evidence for each compound is substantial and replicated in animal research, but the rationale for pairing them is mechanistic: it is based on what each does on its own, not on a study of the combination. Because the two share overlapping repair pathways, isolating the effect of the combination is also difficult to design cleanly.
Because their mechanisms are complementary rather than overlapping. BPC-157 acts locally — promoting angiogenesis and collagen at a specific injury site — while TB-500 acts systemically, supporting cell migration and regeneration across many tissues at once. The pairing is studied on the reasoning that covering both scales addresses more of the repair process than either alone.
They are supplied here as two separate 5mg vials, and there is a practical reason for that. There is no published compatibility or stability data for the two peptides combined in a single solution, so keeping them separate is the conservative handling choice. It also keeps the ratio between them independent, and allows each to be reconstituted, stored and used on its own. Pre-mixed blends are sold elsewhere; separate vials simply remove the stability question and leave the researcher in control.
| Compound | Research area (animal / preclinical) | Reference |
|---|---|---|
| BPC-157 | Tendon & ligament repair (localised) | Chang 2011 |
| BPC-157 | Angiogenesis & gut cytoprotection | Sikirić et al. |
| TB-500 | Cell migration & systemic regeneration | Goldstein et al. |
| TB-500 | Angiogenesis | Malinda 1997 |
Further reading: The Wolverine Stack — why these are supplied as two separate vials
BPC-157
Molecular Formula: C62H98N16O22
Molecular Weight: 1419.5 g/mol
View on PubChem
TB-500 (Thymosin Beta-4)
Molecular Formula: C212H350N56O78S
Molecular Weight: 4963.4 g/mol
View on PubChem
